Safety and Efficacy of Adalimumab in Patients With Moderate to Severely Active Psoriatic Arthritis
Clinical trial NCT00195689 · COMPLETED
Trial details
- NCT number
- NCT00195689
- Sponsor
- Abbott
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2003-08-01
- Enrollment
- 400
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.